Tina Regan, 68, has been touched by cancer personally and has seen the devastating impact it has had on her immediate family. That is why she has pledged to leave a gift in her Will to fund our vital ...
We are very grateful that so many of you recognise the cutting-edge research carried out at The Institute of Cancer Research.
The dedication of these charities, set up when a family has been touched by cancer, drives forward our research immeasurably. We are so grateful to work with such passionate organisations and receive ...
The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...
Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...
Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...
Dr Chris Jones’ group investigates ways to translate basic molecular pathology findings into improved clinical outcomes for children with cancer. Our group is primarily focused on high grade gliomas ...